Search Results

Filter
  • 1-10 of  31,994 results for ""TERIPARATIDE""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Randomized controlled trial of daily teriparatide, weekly high-dose teriparatide, or bisphosphonate in patients with postmenopausal osteoporosis: The TERABIT study.

  • Authors : Chiba K; Department of Orthopedic Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki University Hospital, Japan. Electronic address: .; Okazaki N

Subjects: Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/diagnostic imaging ; Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/drug therapy ; Teriparatide*/Teriparatide*/Teriparatide*/pharmacology

  • Source: Bone [Bone] 2022 Jul; Vol. 160, pp. 116416. Date of Electronic Publication: 2022 Apr 06.Publisher: Elsevier Science Country of Publication: United States NLM ID: 8504048 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Report

Successful Treatment of Atypical Femoral Fracture with Bowed Femur Using Contralateral Intramedullary Nail Combined with Early Daily Teriparatide.

Subjects: Femoral Fractures*/Femoral Fractures*/Femoral Fractures*/complications ; Femoral Fractures*/Femoral Fractures*/Femoral Fractures*/drug therapy ; Femoral Fractures*/Femoral Fractures*/Femoral Fractures*/surgery

  • Source: Acta medica Okayama [Acta Med Okayama] 2022 Jun; Vol. 76 (3), pp. 333-338.Publisher: Okayama University Medical School Country of Publication: Japan NLM ID: 0417611 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Analysis of treatment effect with teriparatide on device-related vertebral osteopenia after lumbar spinal interbody fusion using Hounsfield unit values: A retrospective cohort study.

  • Authors : Miyazaki M; Department of Orthopedic Surgery, Faculty of Medicine, Oita University, Oita, Japan.; Ishihara T

Subjects: Bone Diseases, Metabolic*/Bone Diseases, Metabolic*/Bone Diseases, Metabolic*/drug therapy ; Bone Diseases, Metabolic*/Bone Diseases, Metabolic*/Bone Diseases, Metabolic*/etiology ; Spinal Fusion*/Spinal Fusion*/Spinal Fusion*/adverse effects

  • Source: Medicine [Medicine (Baltimore)] 2022 Jul 15; Vol. 101 (28), pp. e29677. Date of Electronic Publication: 2022 Jul 15.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Electronic Cited Medium: Internet

Record details

×
Academic Journal

Efficacy and Safety of Teriparatide in Beta-Thalassemia Major Associated Osteoporosis: A Real-Life Experience.

  • Authors : Gagliardi I; Section of Endocrinology, Geriatrics & Internal Medicine, Dept of Medical Sciences, University of Ferrara, Via Fossato di Mortara 64/B, 44121, Ferrara, Italy.; Celico M

Subjects: Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/adverse effects ; Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/therapeutic use ; Osteoporosis*/Osteoporosis*/Osteoporosis*/complications

  • Source: Calcified tissue international [Calcif Tissue Int] 2022 Jul; Vol. 111 (1), pp. 56-65. Date of Electronic Publication: 2022 Mar 04.Publisher: Springer Verlag Country of Publication: United States NLM ID: 7905481 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Oral Administration of Isovitexin, a Naturally Occurring Apigenin Derivative Showed Osteoanabolic Effect in Ovariectomized Mice: A Comparative Study with Teriparatide.

  • Authors : Pal S; Division of Endocrinology and Center for Research in Anabolic Skeletal Target in Health and Illness (ASTHI), CSIR-Central Drug Research Institute, Council of Scientific and Industrial Research, Sector 10, Jankipuram Extension, Sitapur Road, Lucknow, 226031, India.; Sharma S

Subjects: Anabolic Agents*/Anabolic Agents*/Anabolic Agents*/pharmacology ; Teriparatide*/Teriparatide*/Teriparatide*/pharmacology; Administration, Oral

  • Source: Calcified tissue international [Calcif Tissue Int] 2022 Aug; Vol. 111 (2), pp. 196-210. Date of Electronic Publication: 2022 Apr 22.Publisher: Springer Verlag Country of Publication: United States NLM ID: 7905481 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The Relationship between the Drug Delivery Properties of a Formulation of Teriparatide Microneedles and the Pharmacokinetic Evaluation of Teriparatide Administration in Rats.

  • Authors : Oh YJ; Department of Bionano Technology and Gachon BioNano Research Institute, Gachon University, Gyeonggi-do, Republic of Korea.; Kang NW

Subjects: Needles* ; Teriparatide*; Administration, Cutaneous

  • Source: Pharmaceutical research [Pharm Res] 2022 May; Vol. 39 (5), pp. 989-999. Date of Electronic Publication: 2022 Apr 19.Publisher: Kluwer Academic/Plenum Publishers Country of Publication: United States NLM ID: 8406521 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Effects of teriparatide and low-intensity aerobic exercise on osteopenia in type 2 diabetes mellitus rats.

  • Authors : Abe K; Department of Orthopedic Surgery, Akita University Graduate School of Medicine, 1-1-1, Hondo, Akita, 010-8543, Japan.; Miyakoshi N

Subjects: Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/pharmacology ; Bone Diseases, Metabolic*/Bone Diseases, Metabolic*/Bone Diseases, Metabolic*/therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/therapy

  • Source: Journal of bone and mineral metabolism [J Bone Miner Metab] 2022 Mar; Vol. 40 (2), pp. 229-239. Date of Electronic Publication: 2022 Jan 28.Publisher: Japanese Society of Bone and Mineral Metabolism Country of Publication: Japan NLM ID: 9436705 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Bone quality in an ovariectomized monkey animal model treated with two doses of teriparatide for either 18 months, or 12 months followed by withdrawal for 6 months.

  • Authors : Paschalis EP; Ludwig Boltzmann Institute for Osteology, at the Hanusch Hospital of OEGK and AUVA Trauma Centre Meidling, 1st Medical Department, Hanusch Hospital, Vienna, Austria. Electronic address: .; Gamsjaeger S

Subjects: Parathyroid Hormone*/Parathyroid Hormone*/Parathyroid Hormone*/pharmacology ; Parathyroid Hormone*/Parathyroid Hormone*/Parathyroid Hormone*/therapeutic use ; Teriparatide*/Teriparatide*/Teriparatide*/pharmacology

  • Source: Bone [Bone] 2022 May; Vol. 158, pp. 116366. Date of Electronic Publication: 2022 Feb 12.Publisher: Elsevier Science Country of Publication: United States NLM ID: 8504048 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Teriparatide with Octacalcium Phosphate Collagen Composite Stimulates Osteogenic Factors.

  • Authors : Kouketsu A; Division of Oral and Maxillofacial Surgery, Department of Oral Medicine and Surgery, Tohoku University Graduate School of Dentistry, Sendai, Japan.; Division of Oral and Maxillofacial Surgery, Department of Medicine of Sensory and Motor Organs, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.

Subjects: Osteogenesis* ; Teriparatide*/Teriparatide*/Teriparatide*/metabolism ; Teriparatide*/Teriparatide*/Teriparatide*/pharmacology

  • Source: Tissue engineering. Part A [Tissue Eng Part A] 2022 Feb; Vol. 28 (3-4), pp. 125-135. Date of Electronic Publication: 2022 Jan 05.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101466659 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Sweep imaging with Fourier transform as a tool with MRI for evaluating the effect of teriparatide on cortical bone formation in an ovariectomized rat model.

  • Authors : Sotozono Y; Department of Orthopaedics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, Japan.; Ikoma K

Subjects: Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/pharmacology ; Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/therapeutic use ; Teriparatide*/Teriparatide*/Teriparatide*/pharmacology

  • Source: BMC musculoskeletal disorders [BMC Musculoskelet Disord] 2022 Jan 03; Vol. 23 (1), pp. 16. Date of Electronic Publication: 2022 Jan 03.Publisher: BioMed Central Country of Publication: England NLM ID: 100968565 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2474

Record details

×
  • 1-10 of  31,994 results for ""TERIPARATIDE""